
Cue Biopharma, Inc.
CUEHealthcare|Biotechnology|US
$18.73
+0.72 (+4.00%)
Tangible Book / Share
$0.36
Cash / Share
$2.74
Ownership Breakdown
87.6%
Float
7.3M
Shares Outstanding
6.4M
Float Shares
Major Holders (13)
Combined: 80.3%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Andrew Gundlach | Holding company | 9.99% | 6,127,662 | Mar 21, 2025 | 13D/G |
| Bleichroeder Holdings LLC | Holding company | 9.99% | 6,127,662 | Mar 21, 2025 | 13D/G |
| Bleichroeder LP | Investment adviser | 9.99% | 6,127,662 | Mar 21, 2025 | 13D/G |
| Mark E. Strome | Individual | 8.50% | 644,916 | Oct 8, 2026 | 13D/G |
| Strome Group, Inc. | Corporation | 8.48% | 643,242 | Oct 8, 2026 | 13D/G |
| Strome Investment Management, LP | IA, PN | 8.48% | 643,242 | Oct 8, 2026 | 13D/G |
| Strome Mezzanine Fund II, LP | Partnership | 7.82% | 593,242 | Oct 8, 2026 | 13D/G |
| Driehaus Capital Management LLC | Investment company | 6.96% | 292,144 | Aug 14, 2026 | 13D/G |
| Shao-Lee Lin | Individual | 6.20% | 467,166 | Aug 21, 2026 | 13D/G |
| Slate Path Capital LP | IA, PN | 1.40% | 918,836 | Feb 14, 2025 | 13D/G |
| David Greenspan | HC, IN | 1.40% | 918,836 | Feb 14, 2025 | 13D/G |
| Strome Dynasty, LLC | Other | 0.66% | 50,000 | Oct 8, 2026 | 13D/G |
| Strome Dynasty, LLC. | Other | 0.38% | 162,629 | May 16, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 3,521,411 acquired · 167,437 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ray Sumita | officer, other: Chief Legal Compliance Officer | Oct 12, 2026 | SELL | 1,844 | $28.05 | $51.7K | Form 4 |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | Oct 12, 2026 | SELL | 1,144 | $28.05 | $32.1K | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Oct 12, 2026 | SELL | 10,000 | $27.50 | $275.0K | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Oct 12, 2026 | SELL | 1,087 | $28.05 | $30.5K | Form 4 |
| Sarraf Pasha | director | Jul 9, 2026 | AWARD | 18,400 | — | — | Form 4 |
| Garzone Pamela | director | Jul 9, 2026 | AWARD | 18,900 | — | — | Form 4 |
| Ray Sumita | officer, other: Chief Legal Compliance Officer | Aug 13, 2026 | OPTION EX. | 18,196 | — | — | Form 4 |
| Ray Sumita | officer, other: Chief Legal Compliance Officer | Aug 13, 2026 | SELL | 2,383 | $29.37 | $70.0K | Form 4 |
| Ray Sumita | officer, other: Chief Legal Compliance Officer | Aug 13, 2026 | SELL | 6,442 | $30.35 | $195.5K | Form 4 |
| Ray Sumita | officer, other: Chief Legal Compliance Officer | Aug 13, 2026 | SELL | 4 | $31.13 | $124.52 | Form 4 |
| Ray Sumita | officer, other: Chief Legal Compliance Officer | Aug 13, 2026 | OPTION EX. | 18,196 | — | — | Form 4 |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | Aug 13, 2026 | OPTION EX. | 13,647 | — | — | Form 4 |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | Aug 13, 2026 | SELL | 1,519 | $29.37 | $44.6K | Form 4 |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | Aug 13, 2026 | SELL | 4,106 | $30.35 | $124.6K | Form 4 |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | Aug 13, 2026 | SELL | 3 | $31.13 | $93.39 | Form 4 |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | Aug 13, 2026 | OPTION EX. | 13,647 | — | — | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Aug 12, 2026 | OPTION EX. | 109,179 | — | — | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Aug 12, 2026 | SELL | 34,225 | $26.99 | $923.7K | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Aug 12, 2026 | SELL | 5,775 | $27.75 | $160.3K | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Aug 13, 2026 | SELL | 5,423 | $27.19 | $147.5K | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Aug 13, 2026 | SELL | 2,375 | $28.11 | $66.8K | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Aug 13, 2026 | SELL | 10,460 | $29.48 | $308.4K | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Aug 12, 2026 | OPTION EX. | 109,179 | — | — | Form 4 |
| Ahlers James M | Chief Financial Officer | Jul 30, 2026 | AWARD | 51,000 | $30.40 | $1.6M | Form 4 |
| Ahlers James M | Chief Financial Officer | Jul 30, 2026 | AWARD | 25,500 | — | — | Form 4 |
| Ahlers James M | Jul 30, 2026 | OTHER | 0 | — | — | Form 4 | |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Jun 1, 2026 | AWARD | 90,906 | $0.00 | $90.91 | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Jun 1, 2026 | AWARD | 45,453 | $11.00 | $500.0K | Form 4 |
| Borie Dominique Christian | officer, other: Chief Medical Officer | Jul 13, 2026 | AWARD | 63,000 | $30.92 | $1.9M | Form 4 |
| Borie Dominique Christian | officer, other: Chief Medical Officer | Jul 13, 2026 | AWARD | 31,500 | — | — | Form 4 |
| Borie Dominique Christian | Jul 13, 2026 | OTHER | 0 | — | — | Form 4 | |
| Garzone Pamela | director | Jul 9, 2026 | AWARD | 21,800 | — | — | Form 4 |
| Camardo Daniel A. | director | Jul 9, 2026 | AWARD | 21,800 | — | — | Form 4 |
| Sarraf Pasha | director | Jul 9, 2026 | AWARD | 21,800 | — | — | Form 4 |
| Meehan Viola Mong | director | Jul 9, 2026 | AWARD | 21,800 | — | — | Form 4 |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | Jul 9, 2026 | AWARD | 40,942 | — | — | Form 4 |
| Ray Sumita | officer, other: Chief Legal Compliance Officer | Jul 9, 2026 | AWARD | 54,589 | — | — | Form 4 |
| Ray Sumita | officer, other: Chief Legal Compliance Officer | Jul 9, 2026 | AWARD | 54,589 | — | — | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Jul 9, 2026 | AWARD | 327,537 | — | — | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Jul 9, 2026 | AWARD | 327,537 | — | — | Form 4 |
| Meluzio Michael Vincent | Jun 1, 2026 | OTHER | 0 | — | — | Form 4 | |
| Ray Sumita | officer, other: Chief Legal Compliance Officer | Jun 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Ray Sumita | officer, other: Chief Legal Compliance Officer | Jun 1, 2026 | OTHER | 109,179 | $30.42 | $3.3M | Form 4 |
| Camardo Daniel A. | director | May 30, 2026 | AWARD | 1,626 | $21.90 | $35.6K | Form 4 |
| Camardo Daniel A. | May 30, 2026 | OTHER | 0 | — | — | Form 4 | |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Jun 1, 2026 | BUY | 90,906 | $0.00 | $90.91 | Form 4 |
| Lin Shao-Lee | director, officer: Chief Executive Officer | Jun 1, 2026 | BUY | 45,453 | $11.00 | $500.0K | Form 4 |
| Meehan Viola Mong | director | May 30, 2026 | AWARD | 1,626 | $21.90 | $35.6K | Form 4 |
| Meehan Viola Mong | May 30, 2026 | OTHER | 0 | — | — | Form 4 | |
| Lin Shao-Lee | Apr 30, 2026 | OTHER | 0 | — | — | Form 4 | |
| Lin Shao-Lee | director, officer: CHIEF EXECUTIVE OFFICER | May 3, 2026 | AWARD | 655,074 | $30.42 | $19.9M | Form 4 |
| Lin Shao-Lee | director, officer: CHIEF EXECUTIVE OFFICER | May 3, 2026 | AWARD | 327,537 | — | — | Form 4 |
| Sandercock Colin | SVP, GENERAL COUNSEL | Apr 9, 2026 | AWARD | 200,000 | $0.29 | $58.0K | Form 4 |
| Warren Lucinda | CHIEF BUSINESS OFFICER | Apr 9, 2026 | AWARD | 250,000 | $0.29 | $72.5K | Form 4 |
| Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | Apr 9, 2026 | AWARD | 100,000 | $0.29 | $29.0K | Form 4 |
| Kiener Peter A | director | Jan 2, 2026 | AWARD | 24,400 | $0.34 | $8.3K | Form 4 |
| Broadfoot Jill Marie | director | Jan 2, 2026 | AWARD | 24,400 | $0.34 | $8.3K | Form 4 |
| Garzone Pamela | director | Jan 2, 2026 | AWARD | 24,400 | $0.34 | $8.3K | Form 4 |
| Morich Frank | director | Jan 2, 2026 | AWARD | 24,400 | $0.34 | $8.3K | Form 4 |
| Verheyen Patrick | director | Jan 2, 2026 | AWARD | 24,400 | $0.34 | $8.3K | Form 4 |
| Sarraf Pasha | director | Jan 2, 2026 | AWARD | 24,400 | $0.34 | $8.3K | Form 4 |
| Sarraf Pasha | director | Dec 30, 2025 | BUY | 77,417 | $0.30 | $23.3K | Form 4 |
| Sarraf Pasha | director | Dec 30, 2025 | BUY | 78,116 | $0.31 | $24.3K | Form 4 |
| Sarraf Pasha | director | Dec 30, 2025 | BUY | 86,947 | $0.32 | $27.6K | Form 4 |
| Sarraf Pasha | director | Dec 30, 2025 | BUY | 77,148 | $0.30 | $23.2K | Form 4 |
| Sarraf Pasha | director | Dec 30, 2025 | BUY | 4,229 | $0.31 | $1.3K | Form 4 |
| Sandercock Colin | SVP, GENERAL COUNSEL | Dec 3, 2025 | AWARD | 70,000 | $0.70 | $49.0K | Form 4 |
| Sandercock Colin | SVP, GENERAL COUNSEL | Sep 26, 2025 | AWARD | 30,000 | $0.70 | $21.0K | Form 4 |
| Warren Lucinda | CHIEF BUSINESS OFFICER | Sep 29, 2025 | AWARD | 125,000 | $0.72 | $90.0K | Form 4 |
| Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | Sep 29, 2025 | AWARD | 50,000 | $0.72 | $36.0K | Form 4 |
| Azam Usman | director, officer: CHIEF EXECUTIVE OFFICER | Sep 29, 2025 | AWARD | 1,875,000 | $0.72 | $1.4M | Form 4 |
| Azam Usman | Sep 29, 2025 | OTHER | 0 | — | — | Form 4 | |
| Broadfoot Jill Marie | director | Jun 4, 2025 | AWARD | 48,800 | $0.62 | $30.3K | Form 4 |
| Broadfoot Jill Marie | Jun 4, 2025 | OTHER | 0 | — | — | Form 4 | |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Mar 21, 2025 | AWARD | 200,000 | $0.99 | $198.0K | Form 4 |
| PASSERI DANIEL R | director, officer: CHIEF EXECUTIVE OFFICER | Mar 21, 2025 | AWARD | 450,000 | $0.99 | $445.5K | Form 4 |
| Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | Mar 21, 2025 | AWARD | 100,000 | $0.99 | $99.0K | Form 4 |
| Sandercock Colin | SVP, GENERAL COUNSEL | Mar 21, 2025 | AWARD | 200,000 | $0.99 | $198.0K | Form 4 |
| Warren Lucinda | CHIEF BUSINESS OFFICER | Mar 21, 2025 | AWARD | 250,000 | $0.99 | $247.5K | Form 4 |
| Levisetti Matteo | Chief Medical Officer | Mar 21, 2025 | AWARD | 250,000 | $0.99 | $247.5K | Form 4 |
| Sarraf Pasha | director | Mar 10, 2025 | AWARD | 48,800 | $1.03 | $50.3K | Form 4 |
| Sarraf Pasha | Mar 10, 2025 | OTHER | 0 | — | — | Form 4 | |
| Verheyen Patrick | director | Jan 2, 2025 | AWARD | 24,400 | $1.09 | $26.6K | Form 4 |
| Garzone Pamela | director | Jan 2, 2025 | AWARD | 24,400 | $1.09 | $26.6K | Form 4 |
| Morich Frank | director | Jan 2, 2025 | AWARD | 24,400 | $1.09 | $26.6K | Form 4 |
| DRISCOLL FREDERICK W | director | Jan 2, 2025 | AWARD | 24,400 | $1.09 | $26.6K | Form 4 |
| Kiener Peter A | director | Jan 2, 2025 | AWARD | 24,400 | $1.09 | $26.6K | Form 4 |
| PASSERI DANIEL R | director, officer: CHIEF EXECUTIVE OFFICER | Dec 16, 2024 | BUY | 30,000 | $1.03 | $30.9K | Form 4 |
| Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | Nov 25, 2024 | AWARD | 200,000 | $1.06 | $212.0K | Form 4 |
| Baker Daniel G. | Nov 25, 2024 | OTHER | 0 | — | — | Form 4 | |
| Warren Lucinda | Sep 3, 2024 | OTHER | 0 | — | — | Form 4 | |
| Warren Lucinda | CHIEF BUSINESS OFFICER | Sep 3, 2024 | AWARD | 350,000 | $0.66 | $231.0K | Form 4 |
| Levisetti Matteo | Chief Medical Officer | Jun 5, 2024 | AWARD | 125,000 | $1.65 | $206.3K | Form 4 |
| Suri Anish | PRESIDENT AND CSO | Jun 5, 2024 | AWARD | 150,000 | $1.65 | $247.5K | Form 4 |
| Fox Michael J | director | Jun 5, 2024 | AWARD | 48,800 | $1.65 | $80.5K | Form 4 |
| Sandercock Colin | SVP, GENERAL COUNSEL | Jun 5, 2024 | AWARD | 60,000 | $1.65 | $99.0K | Form 4 |
| Fox Michael J | director | Jun 5, 2024 | OTHER | 0 | — | — | Form 4 |
| Fox Michael J | director | Jun 5, 2024 | OTHER | 0 | — | — | Form 4 |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Jun 5, 2024 | AWARD | 60,000 | $1.65 | $99.0K | Form 4 |
| Sandercock Colin | SVP, GENERAL COUNSEL | Mar 6, 2024 | AWARD | 175,000 | $1.94 | $339.5K | Form 4 |